These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26781775)

  • 1. Igniting Small-Molecule Drug Discovery.
    Steinhagen H
    ChemMedChem; 2016 Jan; 11(2):148-9. PubMed ID: 26781775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases.
    Shuttleworth S; Townsend P; Silva F; Cecil A; Hill T; Tomassi C; Rogers H; Harrison R
    Prog Med Chem; 2011; 50():109-33. PubMed ID: 21315929
    [No Abstract]   [Full Text] [Related]  

  • 3. Peptides as Therapeutic Agents for Inflammatory-Related Diseases.
    La Manna S; Di Natale C; Florio D; Marasco D
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule compounds with good anti-inflammatory activity reported in the literature from 01/2009 to 05/2021: a review.
    Bian M; Ma QQ; Wu Y; Du HH; Guo-Hua G
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2139-2159. PubMed ID: 34628990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation unveiled: five new studies pave the way. Researchers are zeroing in on the complex role inflammation plays in many diseases and disorders.
    Health News; 2006 Jan; 12(1):3-5. PubMed ID: 16447313
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances at the intersection of chemical biology and medicinal chemistry.
    Tavassoli A
    Future Med Chem; 2015; 7(16):2089-90. PubMed ID: 26571116
    [No Abstract]   [Full Text] [Related]  

  • 7. Discovery of 3,4-diaminocyclobut-3-ene-1,2-dione-based CXCR2 receptor antagonists for the treatment of inflammatory disorders.
    Dwyer MP; Biju P
    Curr Top Med Chem; 2010; 10(13):1339-50. PubMed ID: 20536426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity.
    Hernández-Flórez D; Valor L
    Reumatol Clin; 2016; 12(6):303-306. PubMed ID: 27567299
    [No Abstract]   [Full Text] [Related]  

  • 9. Small molecule approaches to treat autoimmune and inflammatory diseases (Part II): Nucleic acid sensing antagonists and inhibitors.
    Wang X; Liu Y; Han X; Zou G; Zhu W; Shen H; Liu H
    Bioorg Med Chem Lett; 2021 Jul; 44():128101. PubMed ID: 33984476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting RORγt/Th17 axis for autoimmune disorders.
    Isono F; Fujita-Sato S; Ito S
    Drug Discov Today; 2014 Aug; 19(8):1205-11. PubMed ID: 24792721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A concise review on advances in development of small molecule anti-inflammatory therapeutics emphasising AMPK: An emerging target.
    Gejjalagere Honnappa C; Mazhuvancherry Kesavan U
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):562-571. PubMed ID: 27707958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule approaches to treat autoimmune and inflammatory diseases (Part III): Targeting cytokines and cytokine receptor complexes.
    Zheng J; Chen D; Xu J; Ding X; Wu Y; Shen HC; Tan X
    Bioorg Med Chem Lett; 2021 Sep; 48():128229. PubMed ID: 34214508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide Conjugates with Small Molecules Designed to Enhance Efficacy and Safety.
    He R; Finan B; Mayer JP; DiMarchi RD
    Molecules; 2019 May; 24(10):. PubMed ID: 31091786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic drug discovery: breaking through the immune barrier.
    Tough DF; Tak PP; Tarakhovsky A; Prinjha RK
    Nat Rev Drug Discov; 2016 Dec; 15(12):835-853. PubMed ID: 27765940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and pharmacological effects of a novel GPR142 antagonist.
    Murakoshi M; Kuwabara H; Nagasaki M; Xiong YM; Reagan JD; Maeda H; Nara F
    J Recept Signal Transduct Res; 2017 Jun; 37(3):290-296. PubMed ID: 27807998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical Tools and Materials for Biological/Medicinal Applications.
    Yan X; van Hest JCM
    Chem Asian J; 2018 Nov; 13(22):3331-3332. PubMed ID: 30318717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic and structural routes for the rational conversion of peptides into small molecules.
    Scognamiglio PL; Morelli G; Marasco D
    Methods Mol Biol; 2015; 1268():159-93. PubMed ID: 25555725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin and derivatives: useful tools in inflammation and pain management.
    Carullo G; Cappello AR; Frattaruolo L; Badolato M; Armentano B; Aiello F
    Future Med Chem; 2017 Jan; 9(1):79-93. PubMed ID: 27995808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organoselenium Small Molecules and Chromium(III) Complexes for Intervention in Chronic Low-grade Inflammation and Type 2 Diabetes.
    Zhou J; Xu H; Huang K
    Curr Top Med Chem; 2016; 16(8):823-34. PubMed ID: 26311428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory and therapeutic activity of curcumin.
    Srivastava RM; Singh S; Dubey SK; Misra K; Khar A
    Int Immunopharmacol; 2011 Mar; 11(3):331-41. PubMed ID: 20828642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.